ArticleBlood2009

Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells.

Yongchao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.